For example, for metastatic castrate resistant prostate cancer, recommendations range from the type of test (germline and/or somatic) with no specific genes nominated [42, 47] or testing for one gene only (BRCA2) [47] compared to the more comprehensive list recommended by NCCN in Table 4 above. The gene discussed is BRCA2; the disease is prostate carcinoma.